ArticleHaematologica2023

Combination therapy of a PSEN1-selective γ-secretase inhibitor with dexamethasone and an XPO1 inhibitor to target T-cell acute lymphoblastic leukemia.

Charlien Vandersmissen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.